A strategic partnership between Vaxxas and Profenso, an Australian AI company specialising in advanced automation for ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.

To address the demand for rapid, highly specific therapeutic candidates, Creative Biolabs has optimized its comprehensive suite of antibody discovery platforms.

An international research team has succeeded in developing a new version of RNA building blocks with higher chemical reactivity and photosensitivity. This can significantly reduce the production time ...

A genome-editing approach called INSTALL combines single-stranded DNA molecules that evade immune detection with a short double-stranded region that allows recombinase enzymes to insert a DNA sequence ...